Published in Br J Vener Dis on August 01, 1984
Oral sex and the transmission of viral STIs. Sex Transm Infect (1998) 2.50
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
Women with multiple sexual partners: united states, 1988. Am J Public Health (1992) 1.73
Detection of human papillomavirus DNA in anogenital condylomata in men using in situ DNA hybridisation applied to paraffin sections. Genitourin Med (1987) 1.01
Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol (2007) 0.98
Redefining meaningful age groups in the context of disease. Age (Dordr) (2013) 0.78
Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3. PLoS One (2012) 0.77
Sexually transmitted and other genital infections in women with cervical human papillomavirus infection. Infect Dis Obstet Gynecol (1995) 0.75
Biologic response modifiers in gynecologic malignancies. Yale J Biol Med (1988) 0.75
Behavior of cervical intraepithelial neoplasia (CIN) associated with various human papillomavirus (HPV) types. Arch Gynecol Obstet (1993) 0.75
Coexistent chlamydial infections related to natural history of human papillomavirus lesions in uterine cervix. Genitourin Med (1986) 0.75
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Cancer of the cervix: a sexually transmitted infection? Lancet (1974) 6.93
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res (1973) 5.13
Natural history of genital warts. Br J Vener Dis (1971) 4.22
Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol (1977) 2.71
A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol (1969) 2.47
Genital warts. Sex Transm Dis (1978) 1.84
Human cervical cancer as a venereal disease. Cancer Res (1976) 1.53
Adolescent coitus and cervical cancer: associations of related events with increased risk. Cancer Res (1967) 1.35
Relationship of squamous cell carcinoma of the cervix uteri to squamous cell carcinoma of the penis among Puerto rican women married to men with penile carcinoma. Cancer (1969) 1.29
Human papillomavirus lesions in association with cervical dysplasias and neoplasias. Obstet Gynecol (1983) 1.20
Genital cancer in wives of penile cancer patients. Cancer (1979) 1.15
Venereal factors in human cervical cancer: evidence from marital clusters. Cancer (1977) 1.14
Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix. Acta Cytol (1981) 1.12
Mortality of wives of men dying with cancer of the penis. Br J Cancer (1980) 1.08
Abnormal cervical cytology in the teen-ager: a continuing problem. Am J Obstet Gynecol (1976) 1.03
Cervical cancer in younger women. Lancet (1978) 1.03
The human papillomaviruses. Arch Pathol Lab Med (1982) 1.01
Epidemiologic evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancer. Cancer (1968) 0.98
A hypothesis: the role of a high-risk male in the etiology of cervical carcinoma: a correlation of epidemiology and molecular biology. Am J Obstet Gynecol (1976) 0.98
A study of 80 patients with penile carcinoma combined with cervical biopsy study of their wives. Int Surg (1977) 0.97
Dysplasias of uterine cervix: epidemiological aspects: role of age at first coitus and use of oral contraceptives. Cancer (1977) 0.96
Current views on the condylomatous lesions in uterine cervix and their possible relationship to cervical squamous cell carcinoma. Obstet Gynecol Surv (1980) 0.95
The effect of condom use on squamous cell cervical intraepithelial neoplasia. Am J Obstet Gynecol (1981) 0.93
Morphologic survey of the condylomatous lesions in dysplastic and neoplastic epithelium of the uterine cervix. Arch Gynecol (1979) 0.93
Genital warts. Sex Transm Dis (1982) 0.91
Immunopathology of papillomavirus-induced tumors in different tissues. Springer Semin Immunopathol (1982) 0.89
Condylomatous lesions in dysplastic and neoplastic epithelium of the uterine cervix. Surg Gynecol Obstet (1980) 0.86
Condylomatous epithelial changes in the uterine cervix and their relationship to cervical carcinogenesis. Int J Gynaecol Obstet (1980) 0.79
Experience in mass Papanicolaou screening and cytologic observations of teen-age girls. Am J Obstet Gynecol (1976) 0.78
Dysplasia and carcinoma in situ of the uterine cervix: prevalence in very young women (under age 22). A one-year study in a health plan population. Am J Obstet Gynecol (1976) 0.78
Concurrent carcinoma of penis and carcinoma-in situ of the cervix in a married couple. Case report. Br J Obstet Gynaecol (1982) 0.78
Sexual activity as environmental cancer hazard. N Y State J Med (1980) 0.77
Gynecologic disease in young, sexually active women. Am J Obstet Gynecol (1976) 0.77
Concurrent squamous cell carcinoma of the cervix and penis in a married couple. Br J Obstet Gynaecol (1979) 0.77
Intraepithelial neoplasia of the uterine cervix in the teenager. Cancer (1978) 0.77
Model systems for cervical cancer. Cancer Res (1976) 0.77
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet (1998) 5.65
Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology (2000) 3.94
Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract. Lancet (1990) 2.22
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet (2001) 2.03
Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol (1995) 1.85
Rapid detection of rotavirus in stool by latex agglutination: comparison with radioimmunoassay and electron microscopy and clinical evaluation of the test. J Med Virol (1983) 1.84
Regression of warts. An immunological study. Lancet (1975) 1.78
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer (1994) 1.76
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A (2000) 1.66
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg (1983) 1.65
Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer (1993) 1.63
Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis (1994) 1.61
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes. J Virol Methods (1988) 1.58
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet (1997) 1.53
Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol (2001) 1.52
Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. J Clin Oncol (1995) 1.50
Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril (1996) 1.47
A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet (1997) 1.46
Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer (2009) 1.44
Medical student abuse: an international phenomenon. JAMA (1994) 1.41
Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol (2000) 1.41
Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand (1982) 1.41
Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer (1994) 1.40
Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol (1999) 1.38
Wart-virus antibodies and the prognosis of wart disease. Lancet (1972) 1.36
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Weights of placentae from small-for-gestational age infants revisited. Placenta (2001) 1.32
Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol (1983) 1.31
Maternal antibodies in human foetal sera at different stages of gestation. Immunology (1968) 1.29
Transgenic mice aberrantly expressing human ornithine decarboxylase gene. J Biol Chem (1991) 1.29
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res (1994) 1.28
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol (1994) 1.27
High and unchanged sperm counts of Finnish men. Int J Androl (1996) 1.27
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26
Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women. Calcif Tissue Int (1994) 1.24
Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. J Oral Pathol Med (1992) 1.23
Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation. Genitourin Med (1993) 1.23
Report on consensus conference on cervical cancer screening and management. Int J Cancer (2000) 1.20
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol (1989) 1.20
Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol (1986) 1.20
Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol (1997) 1.18
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS (2003) 1.17
Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg (1983) 1.17
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17
The influence of perinatal factors on breast feeding. Acta Paediatr Scand (1983) 1.16
Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer (1993) 1.16
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer (2001) 1.15
Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction. Acta Ophthalmol (Copenh) (1992) 1.14
Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet (1985) 1.13
Analysis of G(1)/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer (2000) 1.13
Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res (1994) 1.13
Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression. Melanoma Res (1999) 1.11
Screening for metastatic malignant melanoma of the uvea revisited. Cancer (1999) 1.10
An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. J Virol Methods (1986) 1.10
Infectious agents in the etiology of esophageal cancer. Gastroenterology (1992) 1.10
Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy. Ultrasound Obstet Gynecol (2002) 1.10
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. J Clin Oncol (1992) 1.10
Malignant fibrous histiocytoma of the vulva. Gynecol Oncol (1987) 1.10
Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10
Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol (1993) 1.10
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09